Human immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: implications for the pathogenesis of HIV-mediated vascular disease.
暂无分享,去创建一个
J. Berman | S. Morgello | E. Eugenin | A. Schecter | M. Klotman | P. Lento | A. Mosoian
[1] J. Berman,et al. Gap Junctions Mediate Human Immunodeficiency Virus-Bystander Killing in Astrocytes , 2007, The Journal of Neuroscience.
[2] H. Sørensen,et al. Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] J. Currier,et al. Management of antiretroviral treatment-related complications. , 2007, Infectious disease clinics of North America.
[4] M. Bukrinsky,et al. Human immunodeficiency virus impairs reverse cholesterol transport from macrophages , 2006, Retrovirology.
[5] G. Rutherford,et al. The epidemiology of HIV and AIDS in the world. , 2006, Collegium antropologicum.
[6] B. Strauss,et al. Outcome of percutaneous coronary intervention in HIV‐infected patients , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[7] B. McManus,et al. Allograft vasculopathy versus atherosclerosis. , 2006, Circulation research.
[8] Melissa R Pfeiffer,et al. Causes of Death among Persons with AIDS in the Era of Highly Active Antiretroviral Therapy: New York City , 2006, Annals of Internal Medicine.
[9] B. Cotter. Endothelial dysfunction in HIV infection , 2006, Current HIV/AIDS reports.
[10] P. Quax,et al. Anti–MCP-1 Gene Therapy Inhibits Vascular Smooth Muscle Cells Proliferation and Attenuates Vein Graft Thickening Both In Vitro and In Vivo , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[11] N. Roudaut,et al. Premature atherosclerosis in HIV positive patients and cumulated time of exposure to antiretroviral therapy (SHIVA study). , 2006, Atherosclerosis.
[12] K. Sliwa,et al. Mapping the emergence of heart disease in a black, urban population in Africa: the Heart of Soweto Study. , 2006, International journal of cardiology.
[13] T. Rabelink,et al. Functional and structural markers of atherosclerosis in human immunodeficiency virus-infected patients. , 2006, Journal of the American College of Cardiology.
[14] P. Lozach,et al. Infection of Dendritic Cells (DCs), Not DC-SIGN-Mediated Internalization of Human Immunodeficiency Virus, Is Required for Long-Term Transfer of Virus to T Cells , 2006, Journal of Virology.
[15] J. Berman,et al. Shedding of PECAM‐1 during HIV infection: a potential role for soluble PECAM‐1 in the pathogenesis of NeuroAIDS , 2006, Journal of leukocyte biology.
[16] S. Lipshultz,et al. Impact of HIV and highly active antiretroviral therapy on leukocyte adhesion molecules, arterial inflammation, dyslipidemia, and atherosclerosis. , 2006, Atherosclerosis.
[17] J. Berman,et al. CCL2/Monocyte Chemoattractant Protein-1 Mediates Enhanced Transmigration of Human Immunodeficiency Virus (HIV)-Infected Leukocytes across the Blood–Brain Barrier: A Potential Mechanism of HIV–CNS Invasion and NeuroAIDS , 2006, The Journal of Neuroscience.
[18] R. D. Wiley,et al. Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[19] R. Steinman,et al. HIV-1 Selectively Infects a Subset of Nonmaturing BDCA1-Positive Dendritic Cells in Human Blood1 , 2006, The Journal of Immunology.
[20] David R. Holtgrave. Causes of the decline in AIDS deaths, United States, 1995–2002: prevention, treatment or both? , 2005, International journal of STD & AIDS.
[21] Leona W Ayers,et al. AIDS-related vasculopathy: evidence for oxidative and inflammatory pathways in murine and human AIDS. , 2005, American journal of physiology. Heart and circulatory physiology.
[22] S. Grinspoon. Metabolic syndrome and cardiovascular disease in patients with human immunodeficiency virus. , 2005, The American journal of medicine.
[23] J. Esko,et al. Contribution of Proteoglycans to Human Immunodeficiency Virus Type 1 Brain Invasion , 2004, Journal of Virology.
[24] P. Gallay. Syndecans and HIV-1 pathogenesis. , 2004, Microbes and infection.
[25] D. Waters,et al. Clinical Features of Acute Coronary Syndromes in Patients With Human Immunodeficiency Virus Infection , 2004, Circulation.
[26] M. Marsh,et al. Infectious HIV-1 assembles in late endosomes in primary macrophages , 2003, The Journal of cell biology.
[27] S. Venkatesan,et al. Distinct mechanisms of agonist-induced endocytosis for human chemokine receptors CCR5 and CXCR4. , 2003, Molecular biology of the cell.
[28] M. Taubman,et al. Chemokine Receptors in Vascular Smooth Muscle , 2003, Microcirculation.
[29] J. Berman,et al. Chemokine-dependent mechanisms of leukocyte trafficking across a model of the blood-brain barrier. , 2003, Methods.
[30] F. Diaz-Griffero,et al. Endocytosis Is a Critical Step in Entry of Subgroup B Avian Leukosis Viruses , 2002, Journal of Virology.
[31] M. Bukrinsky,et al. Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion- and death receptor-controlled pathways , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[32] R. Doms,et al. Evaluation of current approaches to inhibit HIV entry. , 2002, Current drug targets. Infectious disorders.
[33] M. Prevost,et al. Human Immunodeficiency Virus Type 1 Entry into Macrophages Mediated by Macropinocytosis , 2001, Journal of Virology.
[34] M. Galli,et al. Cardiovascular Disease Risk Factors in HIV‐Infected Patients in the HAART Era , 2001, Annals of the New York Academy of Sciences.
[35] C. Mcmanus,et al. HIV envelope gp120 activates human arterial smooth muscle cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[36] G. Barbarini,et al. HIV-associated coronary arteritis in a patient with fatal myocardial infarction. , 2001, The New England journal of medicine.
[37] Z. Xie,et al. HIV gp120 enhances NO production by cardiac myocytes through p38 MAP kinase-mediated NF-kappaB activation. , 2000, American journal of physiology. Heart and circulatory physiology.
[38] Y. Bobryshev. Identification of HIV-1 in the aortic wall of AIDS patients. , 2000, Atherosclerosis.
[39] R. Virmani,et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[40] Douglas S Kwon,et al. DC-SIGN, a Dendritic Cell–Specific HIV-1-Binding Protein that Enhances trans-Infection of T Cells , 2000, Cell.
[41] Weixin Zhao,et al. Human Vascular Smooth Muscle Cells Possess Functional CCR5* , 2000, The Journal of Biological Chemistry.
[42] R. Loire,et al. Accelerated coronary atherosclerosis and arteriosclerosis in young human‐immunodeficiency‐virus‐positive patients , 2000, Coronary artery disease.
[43] J. Weiss,et al. HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes. , 1999, Journal of immunology.
[44] S M Marcovina,et al. Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study. , 1999, Circulation.
[45] P. Libby,et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. , 1998, Molecular cell.
[46] B. Rollins,et al. Tissue Factor Is Induced by Monocyte Chemoattractant Protein-1 in Human Aortic Smooth Muscle and THP-1 Cells* , 1997, The Journal of Biological Chemistry.
[47] J. Fallon,et al. Tissue factor expression in human arterial smooth muscle cells. TF is present in three cellular pools after growth factor stimulation. , 1997, The Journal of clinical investigation.
[48] A. Trkola,et al. Co-receptors for HIV-1 entry. , 1997, Current opinion in immunology.
[49] P. Luciw,et al. Transgenic dissection of HIV genes involved in lymphoid depletion. , 1997, The Journal of clinical investigation.
[50] P. Luciw,et al. Human immunodeficiency virus-associated vasculopathy in transgenic mice , 1997, Journal of virology.
[51] Richard T. Lee,et al. Macrophages and atherosclerotic plaque stability , 1996, Current opinion in lipidology.
[52] G. Hansson,et al. Immune mechanisms in atherosclerosis. , 1994, Coronary artery disease.
[53] Jeani Chang,et al. Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection. , 1993, The American journal of medicine.
[54] M. Burdick,et al. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. , 1992, The Journal of clinical investigation.
[55] R. Terkeltaub,et al. Monocyte chemoattractant protein-1 (MCP-1) expression in human articular cartilage. Induction by peptide regulatory factors and differential effects of dexamethasone and retinoic acid. , 1992, The Journal of clinical investigation.
[56] R. Terkeltaub,et al. Production of monocyte chemoattractant protein-1 by inflamed synovial tissue and cultured synoviocytes. , 1992, Journal of immunology.
[57] D. Steinberg,et al. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[58] W. Grody,et al. Infection of the heart by the human immunodeficiency virus. , 1990, The American journal of cardiology.
[59] M. Kielian,et al. Mechanisms of enveloped virus entry into cells. , 1990, Molecular biology & medicine.
[60] L. Highleyman. Mortality trends: toward a new definition of AIDS? , 2005, BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation.
[61] G. Whittaker,et al. Viral entry. , 2005, Current topics in microbiology and immunology.
[62] R. Doms,et al. HIV-1 entry and its inhibition. , 2003, Current topics in microbiology and immunology.
[63] R. Brack-Werner. Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis. , 1999, AIDS.
[64] R. Loire,et al. Coronary artery lesions and human immunodeficiency virus infection. , 1993, Research in virology.